Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study

被引:0
|
作者
Ross, Paul J.
Ma, Yuk Ting
Palmer, Daniel H.
Lythgoe, Mark Peter
Merrick, Sophie
Samson, Adel
Rao, Ankit Rohit
Basu, Bristi
Prasad, Debi
Dhillon, Tony
Lau, David
Darby, Suzanne
Orr, James
Margetts, Jane
Hubner, Richard
Baijal, Shobhit
Sharma, Rohini
Faluyi, Olusola Olusesan
Lee, Lennard
Thillai, Kiruthikah
机构
[1] Guys & St Thomas NHS Fdn Trust, London, England
[2] Kings Coll Hosp NHS Fdn Trust, London, England
[3] Univ Birmingham, Birmingham, W Midlands, England
[4] Univ Liverpool, Liverpool, Merseyside, England
[5] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[6] Imperial Coll London, London, England
[7] East & North Herts NHS Trust, Stevenage, Herts, England
[8] Univ Leeds, Leeds, W Yorkshire, England
[9] Nottingham City Hosp, Nottingham, England
[10] Univ Cambridge, Cambridge, England
[11] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[12] Kings Coll Hosp London, London, England
[13] Univ Surrey, Royal Surrey Hosp, Guildford, Surrey, England
[14] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[15] Weston Pk Hosp, Sheffield, S Yorkshire, England
[16] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
[17] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[18] Christie NHS Fdn Trust, Manchester, Lancs, England
[19] Birmingham Heartlands Hosp, Birmingham, W Midlands, England
[20] Clatterbridge Canc Ctr, Wirral, Merseyside, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
499
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
    Kurvi Patwala
    David Stephen Prince
    Yael Celermajer
    Waafiqa Alam
    Eldho Paul
    Simone Irene Strasser
    Geoffrey William McCaughan
    Paul Gow
    Siddharth Sood
    Elise Murphy
    Stuart Roberts
    Elliot Freeman
    Elizabeth Stratton
    Scott Anthony Davison
    Miriam Tania Levy
    McCawley Clark-Dickson
    Vi Nguyen
    Sally Bell
    Amanda Nicoll
    Ashley Bloom
    Alice Unah Lee
    Marno Ryan
    Jessica Howell
    Zina Valaydon
    Alexandra Mack
    Ken Liu
    Anouk Dev
    Hepatology International, 2022, 16 : 1170 - 1178
  • [22] Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
    Welland, Sabrina
    Leyh, Catherine
    Finkelmeier, Fabian
    Jefremow, Andre
    Shmanko, Kateryna
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Jeliazkova, Petia
    Best, Jan
    Fruendt, Thorben W.
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Greil, Richard
    Fricke, Christina
    Sookthai, Disorn
    Guenther, Rainer
    Schmiderer, Andreas
    Wege, Henning
    Venerito, Marino
    Ehmer, Ursula
    Mueller, Martina
    Strassburg, Christian P.
    Weinmann, Arndt
    Siebler, Jurgen
    Waidmann, Oliver
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    LIVER CANCER, 2022, 11 (03) : 219 - 232
  • [23] Efficacy and safety of regorafenib alone or in combinations in the second-line setting for advanced hepatocellular carcinoma: A multicenter real-world study.
    Zhang, Wei
    Zhao, Yanrong
    Ma, Guixiang
    Zhang, Yu
    Guo, Yuan
    Chen, Zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Real-world experience of atezolizumab/bevacizumab in hepatocellular carcinoma
    Ha, Yeonjung
    Cheon, Jaekyung
    Hwang, Seong Gyu
    Chon, Hong Jae
    JOURNAL OF HEPATOLOGY, 2021, 75 : S526 - S527
  • [25] PARALLEL SESSION - AID EXPERIENCE IN THE REAL-WORLD - IN THE UNITED KINGDOM
    Wilmot, E.
    Crabtree, T.
    Griffin, T.
    Yap, Y.
    Narendran, P.
    Gallen, G.
    Furlong, N.
    Cranston, I.
    Chakera, A.
    Philbey, C.
    Karamat, M.
    Saraf, S.
    Kamaruddin, S.
    Gurnell, E.
    Chapman, A.
    Hussain, S.
    Elliott, J.
    Ryder, R.
    Hammond, P.
    Lumb, A.
    Choudhary, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A10 - A10
  • [26] Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in the United States (US): Final analysis of the prospective, observational REFINE study
    Kaseb, Ahmed Omar
    Cabrera, Roniel
    Iyer, Renuka
    Parikh, Neehar
    Kalman, Richard
    Ozgurdal, Kirhan
    Khan, Javeed
    Babajanyan, Svetlana
    Finn, Richard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Efficacy and safety of REGORAFENIB in real life in the treatment of hepatocellular carcinoma. Multicenter experience
    Fraile, M.
    Ferrer, M. T.
    Matilla, A. M.
    Lledo, J. L.
    Minguez, B.
    Hernandez, A.
    Perello, C.
    Fernandez-Castroagudin, J.
    de Lope, C. R.
    Aguilar, M. D. E.
    Montoliu, S.
    Sala, M.
    Romero-Gutierrez, M.
    Pascual, S.
    Urquijo, J. J.
    Arraez, D. E. M.
    Rodriguez, M. J. B.
    Varela, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S15 - S15
  • [28] Real-Life Experience of Regorafenib in Patients With Advanced Hepatocellular Carcinoma
    Hou, Jing-Yu
    Xiao, Ya-ting
    Huang, Jing-Bo
    Jiang, Xin-Hua
    Jiang, Kai
    Li, Xun
    Xu, Li
    Chen, Min-Shan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis
    Diaz-Gonzalez, Alvaro
    Sanduzzi-Zamparelli, Marco
    Fonseca, Leonardo G.
    Di Costanzo, Giovan G.
    Alves, Rogerio
    Iavarone, Massimo
    Leal, Cassia
    Sacco, Rodolfo
    Matilla, Ana M.
    Hernandez-Guerra, Manuel
    Aballay Soteras, Gabriel
    Woerns, Marcus-Alexander
    Pinter, Matthias
    Varela, Maria
    Ladekarl, Morten
    Chagas, Aline L.
    Minguez, Beatriz
    Arenas, Juan, I
    Granito, Alessandro
    Sanchez-Torrijos, Yolanda
    Rojas, Angela
    Rodriguez de Lope, Carlos
    Alvares-da-Silva, Mario R.
    Pascual, Sonia
    Rimassa, Lorenza
    Lledo, Jose L.
    Huertas, Carlos
    Sangro, Bruno
    Giannini, Edoardo G.
    Delgado, Manuel
    Vergara, Mercedes
    Perello, Christie
    Lue, Alberto
    Sala, Margarita
    Gallego, Adolfo
    Coll, Susanna
    Hernaez, Tania
    Pinero, Federico
    Pereira, Gustavo
    Franca, Alex
    Marin, Juan
    Anders, Margarita
    Mello, Vivianne
    Lozano, Mar
    Nault, Jean C.
    Menendez, Josemaria
    Garcia Juarez, Ignacio
    Bruix, Jordi
    Reig, Maria
    LIVER INTERNATIONAL, 2020, 40 (06) : 1467 - 1476
  • [30] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Persano, Mara
    Rimini, Margherita
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Rimassa, Lorenza
    Presa, Jose
    Masi, Gianluca
    Yoo, Changhoon
    Lonardi, Sara
    Tovoli, Francesco
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Pressiani, Tiziana
    Kawaguchi, Takumi
    Montes, Margarida
    Vivaldi, Caterina
    Solda, Caterina
    Piscaglia, Fabio
    Hiraoka, Atsushi
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Iavarone, Massimo
    Di Costanzo, Giovanni
    Marra, Fabio
    Scartozzi, Mario
    Tamburini, Emiliano
    Cabibbo, Giuseppe
    Foschi, Francesco Giuseppe
    Silletta, Marianna
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5591 - 5602